2018 ESCMID意见书:脓毒症精准医疗

2018-03-24 欧洲临床微生物与感染性疾病学会 Clin Microbiol Infect. 2018 Mar 24.

我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关,本文主要总结了关于脓毒症精准医疗的最新证据,强调了从理论到实践的转换,并对脓毒症的管理以及未来的研究提供了新的框架和建议。

中文标题:

2018 ESCMID意见书:脓毒症精准医疗

英文标题:

Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases

发布日期:

2018-03-24

简要介绍:

我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关,本文主要总结了关于脓毒症精准医疗的最新证据,强调了从理论到实践的转换,并对脓毒症的管理以及未来的研究提供了新的框架和建议。

 

拓展指南:脓毒症相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 ESCMID意见书:脓毒症精准医疗)] GetToolGuiderByIdResponse(projectId=1, id=1c1bd1c001582350, title=2018 ESCMID意见书:脓毒症精准医疗, enTitle=Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases, guiderFrom=Clin Microbiol Infect. 2018 Mar 24., authorId=null, author=, summary=我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关,本文主要总结了关于脓毒症精准医疗的最新证据,强调了从理论到实践的转换,并对脓毒症的管理以及未来的研究提供了新的框架和建议。 , cover=, journalId=null, articlesId=null, associationId=166, associationName=欧洲临床微生物与感染性疾病学会, associationIntro=欧洲临床微生物与感染性疾病学会(ESCMID)成立于1983年,在德国注册。现在世界各地的正式会员有4100余人。它在微生物学和传染病学领域具有一定的影响力。, copyright=0, guiderPublishedTime=Sat Mar 24 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关,本文主要总结了关于脓毒症精准医疗的最新证据,强调了从理论到实践的转换,并对脓毒症的管理以及未来的研究提供了新的框架和建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>脓毒症</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=b93771c0015583dd" title="日本脓毒症和脓毒性休克的管理指南" target=_blank>日本脓毒症和脓毒性休克的管理指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=76c561c0015a0413" title="脓毒症液体治疗急诊专家共识" target=_blank>脓毒症液体治疗急诊专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=668c31c001a900de" title="2017 SOMANZ指南:妊娠期脓毒症的调查和管理" target=_blank>2017 SOMANZ指南:妊娠期脓毒症的调查和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=47e321c001a09274" title="拯救脓毒症运动:脓毒症与感染性休克治疗国际指南(2016)的进展与评论" target=_blank>拯救脓毒症运动:脓毒症与感染性休克治疗国际指南(2016)的进展与评论</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7400c1c001a091cd" title="2016 拯救脓毒运动:脓毒症和脓毒性休克的管理国际指南(中文版)" target=_blank>2016 拯救脓毒运动:脓毒症和脓毒性休克的管理国际指南(中文版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%84%93%E6%AF%92%E7%97%87" target=_blank>有关脓毒症更多指南</a></ul>, tagList=[TagDto(tagId=1337, tagName=脓毒症), TagDto(tagId=25196, tagName=精准医疗)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7301, appHits=550, showAppHits=19, pcHits=5061, showPcHits=2425, likes=123, shares=16, comments=10, approvalStatus=1, publishedTime=Sat Apr 21 20:55:52 CST 2018, publishedTimeString=2018-03-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 21 20:55:52 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:30:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESCMID意见书:脓毒症精准医疗)])
2018 ESCMID意见书:脓毒症精准医疗
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=958956, encodeId=9202958956be, content=youyong, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210421/7febfb148fba4f999d43148c18e60da3/f3104c12a2ac4398bdfcb03da5b99240.jpg, createdBy=46fb5477498, createdName=ms2000000159050008, createdTime=Wed Apr 21 02:05:52 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900384, encodeId=c66d90038414, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:35:33 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309489, encodeId=9ad1309489d6, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:31:23 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308956, encodeId=2ae8308956fc, content=我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关.本文主要总结了关于脓毒症精准医疗的最新证据.强调了从理论到实践的转换.并对脓毒症的管理以及未来的研究提供了新的框架和建议. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Apr 24 22:44:54 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308847, encodeId=741e30884eab, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Apr 24 12:16:43 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2021-04-21 ms2000000159050008

    youyong

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=958956, encodeId=9202958956be, content=youyong, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210421/7febfb148fba4f999d43148c18e60da3/f3104c12a2ac4398bdfcb03da5b99240.jpg, createdBy=46fb5477498, createdName=ms2000000159050008, createdTime=Wed Apr 21 02:05:52 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900384, encodeId=c66d90038414, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:35:33 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309489, encodeId=9ad1309489d6, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:31:23 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308956, encodeId=2ae8308956fc, content=我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关.本文主要总结了关于脓毒症精准医疗的最新证据.强调了从理论到实践的转换.并对脓毒症的管理以及未来的研究提供了新的框架和建议. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Apr 24 22:44:54 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308847, encodeId=741e30884eab, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Apr 24 12:16:43 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2020-11-19 titiwangsunny

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=958956, encodeId=9202958956be, content=youyong, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210421/7febfb148fba4f999d43148c18e60da3/f3104c12a2ac4398bdfcb03da5b99240.jpg, createdBy=46fb5477498, createdName=ms2000000159050008, createdTime=Wed Apr 21 02:05:52 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900384, encodeId=c66d90038414, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:35:33 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309489, encodeId=9ad1309489d6, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:31:23 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308956, encodeId=2ae8308956fc, content=我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关.本文主要总结了关于脓毒症精准医疗的最新证据.强调了从理论到实践的转换.并对脓毒症的管理以及未来的研究提供了新的框架和建议. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Apr 24 22:44:54 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308847, encodeId=741e30884eab, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Apr 24 12:16:43 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2018-04-26 大爰

    学习了谢谢分享!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=958956, encodeId=9202958956be, content=youyong, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210421/7febfb148fba4f999d43148c18e60da3/f3104c12a2ac4398bdfcb03da5b99240.jpg, createdBy=46fb5477498, createdName=ms2000000159050008, createdTime=Wed Apr 21 02:05:52 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900384, encodeId=c66d90038414, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:35:33 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309489, encodeId=9ad1309489d6, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:31:23 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308956, encodeId=2ae8308956fc, content=我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关.本文主要总结了关于脓毒症精准医疗的最新证据.强调了从理论到实践的转换.并对脓毒症的管理以及未来的研究提供了新的框架和建议. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Apr 24 22:44:54 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308847, encodeId=741e30884eab, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Apr 24 12:16:43 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2018-04-24 有备才能无患

    我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关.本文主要总结了关于脓毒症精准医疗的最新证据.强调了从理论到实践的转换.并对脓毒症的管理以及未来的研究提供了新的框架和建议. ?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=958956, encodeId=9202958956be, content=youyong, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210421/7febfb148fba4f999d43148c18e60da3/f3104c12a2ac4398bdfcb03da5b99240.jpg, createdBy=46fb5477498, createdName=ms2000000159050008, createdTime=Wed Apr 21 02:05:52 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900384, encodeId=c66d90038414, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6a51476719, createdName=titiwangsunny, createdTime=Thu Nov 19 09:35:33 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309489, encodeId=9ad1309489d6, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Apr 26 14:31:23 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308956, encodeId=2ae8308956fc, content=我们目前对脓毒症的病理生理学和管理的理解与临床试验缺乏进展相关.本文主要总结了关于脓毒症精准医疗的最新证据.强调了从理论到实践的转换.并对脓毒症的管理以及未来的研究提供了新的框架和建议. ?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Apr 24 22:44:54 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308847, encodeId=741e30884eab, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Apr 24 12:16:43 CST 2018, time=2018-04-24, status=1, ipAttribution=)]
    2018-04-24 131****1460

    学习了受益匪浅

    0